5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      [Herpes zoster and postherpetic neuralgia].

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Herpes zoster develops by endogenous reactivation of varizella zoster virus (VZV). Incidence increases with age. Females are more frequently affected than males. The reactivation rate in seropositive individuals is about 20 %. After a short prodromal stage, herpetiform-grouped vesicles appear in segmental arrangement. Pain and paresthesia are typical zoster symptoms. Complications like bacterial superinfections, vasculopathy, paresis, and oculopathy may occur. During pregnancy herpes zoster is a threat for mother and child. Among elderly patients, cardiovascular risk is increased during the first week of herpes zoster infection. Postherpetic neuropathy is feared. Diagnosis can be made clinically and by the use of polymerase chain reaction. First-line treatment is systemic antiviral drug therapy with either acyclovir or brivudine. Adjuvant therapies consist of pain management and topical treatment.

          Related collections

          Author and article information

          Journal
          Hautarzt
          Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
          Springer Nature America, Inc
          1432-1173
          0017-8470
          Aug 2016
          : 67
          : 8
          Affiliations
          [1 ] Klinik für Dermatologie und Allergologie, Krankenhaus Dresden-Friedrichstadt, Städtisches Klinikum Dresden, Friedrichstr. 41, 01067, Dresden, Deutschland. wollina-uw@khdf.de.
          [2 ] Neurologische Klinik, Krankenhaus Dresden-Neustadt, Städtisches Klinikum Dresden, Industriestr. 40, 01129, Dresden, Deutschland.
          Article
          10.1007/s00105-016-3834-y
          10.1007/s00105-016-3834-y
          27389412
          131469de-e666-43a7-a96b-0d72572057f8
          History

          Reactivation,Polymerase chain reaction,Brivudine,Vaccination,Acyclovir

          Comments

          Comment on this article